#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodermatitis Neuroendocrine carcinoma metastatic Superficial vein thrombosis Infertility male Factor VIII deficiency Astrocytoma malignant Craniocerebral injury Allogenic stem cell transplantation Carcinoid syndrome Nephrotic syndrome Lymphangiosarcoma Retinitis pigmentosa Infantile apnoea Lymphangioma Loeys-Dietz syndrome More trials…

    Learn about Rare Diseases

    Haemophilia B without inhibitors Acute respiratory distress syndrome – Diagnostics Glomerulonephritis membranoproliferative – Life with Disease Castleman’s disease – Treatment Cytokine release syndrome – Diagnostics Angiosarcoma metastatic – Treatment Systemic sclerosis pulmonary – Basic Information KBG syndrome – Trials in Disease Myxofibrosarcoma – Diagnostics Pulmonary sarcoidosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vanglusagene Ensiparvovec Cefiderocol Bms-986458 Bt8009 LUMC-BOB1-B7-TCR.1 Lebrikizumab Pentixafor Gallium Ga-68 DICLOFENAC POTASSIUM Berubicin Hydrochloride Argipressin Dorzolamide Peginterferon Alfa-2A VORMATRIGINE Alxn2220 Lbl-007 Aciclovir Nadroparin Calcium Odm-208 Follitropin Delta INCB123667 More therapies…

    Learn about Your Condition

    Adenocarcinoma Porphyria non-acute Cachexia Cardiovascular disorder Pleural mesothelioma malignant Insomnia Genital infection female Postpartum haemorrhage Diffuse large B-cell lymphoma Phaeochromocytoma Giant cell arteritis Mantle cell lymphoma stage III Renal cell carcinoma Epileptic encephalopathy Infantile apnoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute lymphocytic leukaemia

  • Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Hydrocortisone Sodium Phosphate
    • Hydrocortisone Sodium Succinate
    • Inotuzumab Ozogamicin
    Belgium Denmark Estonia Finland France Germany +8

  • Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Lymphocytic leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Isatuximab
    • Ponatinib
    • Blinatumomab
    Belgium France

  • Study of Dasatinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with MAPK/SRC Pathway Mutation

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    • Precursor T-lymphoblastic lymphoma/leukaemia refractory
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Dasatinib
    • Venetoclax
    Austria Belgium Denmark Finland France Germany +5

  • Study on CART 19/22 T Cells and CART45RA-NKG2D Cells for Treating Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents, and Young Adults

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Cart 19/22 T Cells
    • Cart45Ra-Nkg2D Cells
    Spain

  • Study of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Dexamethasone Acetate
    • Blinatumomab
    • Cyclophosphamide
    Germany

  • Long‑term safety study of S68587 (allogeneic CD19 CAR T‑cells with TRAC and CD52 disruption) in patients with advanced lymphoid leukemia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    France
Previous Page
1 2 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!